Non-Small Cell Lung Cancer | Proceedings From Our Webinar on Promising Investigational Agents and Strategies for Patients with Metastatic Non-Small Cell Lung Cancer Who Experience Disease Progression

Featuring perspectives from Dr Edward Garon, including the following topics: Introduction: Metastatic Non-Small Cell Lung Cancer (NSCLC) in Clinical Practice (0:00) Sequencing of Therapies in Metastatic NSCLC (3:27) Case: A man in his mid-60s with metastatic adenocarcinoma of the lung (PD-L1 60%, TMB 14 mut/Mb) — Jeremy Lorber, MD (14:27) Case: A man in his late 60s with metastatic adenocarcinoma of the lung and brain metastases — Susmitha Apuri, MD (21:55) New Agents Part 1 — Antibody-Drug Conjugates (27:07) New Agents Part 2 — Other Novel Strategies (42:09) Clinical Situations for Special Consideration (53:33) Case: A man in his late 50s with metastatic NSCLC and no actionable mutations — Sandip Patel, MD (55:33) Case: A man in his mid-60s with metastatic adenocarcinoma of the lung (HER2 amplification) — Henna Malik, MD (57:59) CME information and select publications